{
    "clinical_study": {
        "@rank": "14873", 
        "arm_group": [
            {
                "arm_group_label": "Triamcinolone acetonide", 
                "arm_group_type": "Active Comparator", 
                "description": "The study group will receive an intraoperative intracameral injection of triamcinolone acetonide"
            }, 
            {
                "arm_group_label": "Prednisolone syrup", 
                "arm_group_type": "Active Comparator", 
                "description": "The control group will receive prednisolone syrup postoperatively"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study is to investigate the outcomes of congenital cataract surgery\n      when injecting intraoperative intracameral triamcinolone versus the postoperative use of\n      oral prednisolone.\n\n      This is a prospective, randomized clinical trial. Sixty children will be submitted to\n      congenital cataract surgery younger than 2 years of age. They will be randomly divided in\n      two groups. The study group will receive an intraoperative intracameral triamcinolone\n      acetonide injection. The control group will receive prednisolone syrup postoperatively. The\n      surgical outcomes will be assessed after one year."
        }, 
        "brief_title": "Cataract Surgery With Intracameral Triamcinolone in Infants", 
        "condition": "Cataract", 
        "condition_browse": {
            "mesh_term": "Cataract"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients younger than 2 years of age\n\n          -  Unilateral or bilateral congenital cataracts compromising the red reflex\n\n        Exclusion Criteria:\n\n          -  Corneal opacity\n\n          -  Glaucoma\n\n          -  Aniridia\n\n          -  Subluxated cataract\n\n          -  Traumatic cataract\n\n          -  Complex microphthalmia\n\n          -  Persistant hyperplastic primary vitreous\n\n          -  Retinal detachment\n\n          -  Patients with intraoperative complications, such as IOL implanted in the sulcus"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "2 Years", 
            "minimum_age": "6 Weeks"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01800708", 
            "org_study_id": "1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Triamcinolone acetonide", 
                "intervention_name": "Triamcinolone acetonide", 
                "intervention_type": "Drug", 
                "other_name": "Triancinolona Ophthalmos"
            }, 
            {
                "arm_group_label": "Prednisolone syrup", 
                "intervention_name": "Prednisolone syrup", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Triamcinolone hexacetonide", 
                "Prednisolone", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Triamcinolone", 
                "Triamcinolone Acetonide", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate", 
                "Triamcinolone diacetate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Recife", 
                    "country": "Brazil", 
                    "state": "Pernambuco", 
                    "zip": "50070020"
                }, 
                "name": "Altino Ventura Foundation"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Use of Intraocular Triamcinolone in the Perioperative Period of Congenital Cataract Surgery", 
        "overall_official": {
            "affiliation": "Funda\u00e7\u00e3o Altino Ventura", 
            "last_name": "Marcelo Ventura, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Visual axis obscuration will be evaluated under sedation, with a dilated pupil. All patients will be classified by the principal investigator as having or not a significant visual axis obscuration, based on the red reflex.", 
                "measure": "Visual axis obscuration", 
                "safety_issue": "No", 
                "time_frame": "1 year after surgery"
            }, 
            {
                "measure": "Intraocular pressure", 
                "safety_issue": "Yes", 
                "time_frame": "1 year after surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01800708"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Funda\u00e7\u00e3o Altino Ventura", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Funda\u00e7\u00e3o Altino Ventura", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}